These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 8402637)

  • 21. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
    Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.
    Haberkorn U; Oberdorfer F; Gebert J; Morr I; Haack K; Weber K; Lindauer M; van Kaick G; Schackert HK
    J Nucl Med; 1996 Jan; 37(1):87-94. PubMed ID: 8544010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase.
    Chung-Faye GA; Chen MJ; Green NK; Burton A; Anderson D; Mautner V; Searle PF; Kerr DJ
    Gene Ther; 2001 Oct; 8(20):1547-54. PubMed ID: 11704815
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic effect of 5-fluorocytosine on cytosine deaminase gene transduced Wilms' tumor xenograft in nude mice].
    Bi Y; Gao J; Xu D
    Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):113-5. PubMed ID: 11776635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anticancer effects of cytosine deaminase gene/5-fluorocytosine therapies to ovarian cancer in vivo].
    Yao Y; Peng Z; Wang H; Li Q; Liu S
    Zhonghua Fu Chan Ke Za Zhi; 2002 Apr; 37(4):195-7. PubMed ID: 12133407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S; McGuire JJ; Rustum YM
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenovirus-mediated GM-CSF gene and cytosine deaminase gene transfer followed by 5-fluorocytosine administration elicit more potent antitumor response in tumor-bearing mice.
    Cao X; Ju DW; Tao Q; Wang J; Wan T; Wang BM; Zhang W; Hamada H
    Gene Ther; 1998 Aug; 5(8):1130-6. PubMed ID: 10326037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced antitumor activity of 5-fluorouracil in combination with 2'-deoxyinosine in human colorectal cell lines and human colon tumor xenografts.
    Ciccolini J; Peillard L; Evrard A; Cuq P; Aubert C; Pelegrin A; Formento P; Milano G; Catalin J
    Clin Cancer Res; 2000 Apr; 6(4):1529-35. PubMed ID: 10778986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
    Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
    J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumoral conversion of 5-fluorocytosine to 5-fluorouracil by monoclonal antibody-cytosine deaminase conjugates: noninvasive detection of prodrug activation by magnetic resonance spectroscopy and spectroscopic imaging.
    Aboagye EO; Artemov D; Senter PD; Bhujwalla ZM
    Cancer Res; 1998 Sep; 58(18):4075-8. PubMed ID: 9751613
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intratumoral generation of 5-fluorouracil mediated by an antibody-cytosine deaminase conjugate in combination with 5-fluorocytosine.
    Wallace PM; MacMaster JF; Smith VF; Kerr DE; Senter PD; Cosand WL
    Cancer Res; 1994 May; 54(10):2719-23. PubMed ID: 8168103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas.
    Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY
    Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter.
    Cao G; Kuriyama S; Gao J; Kikukawa M; Cui L; Nakatani T; Zhang X; Tsujinoue H; Pan X; Fukui H; Qi Z
    Gene Ther; 1999 Jan; 6(1):83-90. PubMed ID: 10341879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.
    Mullen CA; Coale MM; Lowe R; Blaese RM
    Cancer Res; 1994 Mar; 54(6):1503-6. PubMed ID: 8137255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
    Topf N; Worgall S; Hackett NR; Crystal RG
    Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma model.
    Ueda K; Iwahashi M; Nakamori M; Nakamura M; Matsuura I; Yamaue H; Tanimura H
    Cancer Res; 2001 Aug; 61(16):6158-62. PubMed ID: 11507067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Experimental study on human pancreatic carcinoma treated by cytosine deaminase gene therapy].
    Zhang S; Yuan S
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):249-51. PubMed ID: 11798763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective augmentation of radiation effects by 5-fluorocytosine on murine B16(F10) melanoma cells transfected with cytosine deaminase gene.
    Szary J; Missol E; Tarnawski R; Szala S
    Cancer Gene Ther; 1997; 4(4):269-72. PubMed ID: 9253513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the human carcinoembryonic antigen promoter core region in colorectal carcinoma-selective cytosine deaminase gene therapy.
    Cao G; Kuriyama S; Cui L; Nagao S; Pan X; Toyokawa Y; Zhang X; Nishiwaki I; Qi Z
    Cancer Gene Ther; 1999; 6(6):572-80. PubMed ID: 10608354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene.
    Ramnaraine M; Pan W; Goblirsch M; Lynch C; Lewis V; Orchard P; Mantyh P; Clohisy DR
    Cancer Res; 2003 Oct; 63(20):6847-54. PubMed ID: 14583482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.